Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Friday, February 27, 2026

DASH diet linked to lower risk of cognitive decline

 You'll have to ask your competent? doctor for the EXACT SPECIFIC VERSION OF THIS! You wouldn't want to do it wrong, would you? No excuses are allowed.

DASH diet linked to lower risk of cognitive decline

In a large prospective analysis of 159,347 adults from the Nurses’ Health Study, Nurses’ Health Study II, and Health Professionals Follow-Up Study, greater adherence to 6 established healthy dietary patterns was consistently associated with lower risk of subjective cognitive decline, with the Dietary Approaches to Stop Hypertension (DASH) diet showing the strongest effect and the most robust link to better objectively measured global cognition.

In the study, published in JAMA Neurology, individuals in the highest versus lowest decile of DASH adherence had 41% lower odds of subjective cognitive decline, reinforcing dietary quality as a modifiable strategy clinicians can emphasise to support long-term cognitive health.

“These findings support the importance of healthy eating as part of midlife brain-health strategies and motivate pragmatic and implementation research to translate these findings into scalable programs,” wrote Hui Chen, PhD, Harvard School of Public Health, Boston, Massachusetts, and colleagues.

The researchers assessed 6 dietary pattern scores, including the Alternate Healthy Eating Index 2010, the DASH diet score, the Healthful Plant-Based Diet Index, the Planetary Health Diet Index, and the reversed empirical dietary indices for hyperinsulinemia and inflammatory pattern.

Dietary intake was repeatedly assessed using validated food frequency questionnaires, and cognitive outcomes were evaluated through self-reported measures of perceived decline and, in a subset, telephone-based cognitive testing, with analyses conducted across several decades of follow-up.

Higher adherence to all 6 dietary patterns was associated with significantly lower risk of subjective cognitive decline, with the DASH diet demonstrating the strongest association (risk ratio = 0.59 comparing highest vs lowest adherence) and the most robust link to better global cognitive scores.

Diets rich in vegetables and fish and lower in red and processed meats were particularly associated with favorable outcomes, underscoring the role of cardiometabolic-friendly dietary patterns as a potentially modifiable strategy to preserve long-term cognitive health.

While subgroup analyses hinted that lifestyle factors such as physical activity might modify these associations, the study was not powered to formally test interactions, underscoring the need for larger studies and long-term clinical trials. 

Reference: https://jamanetwork.com/journals/jamaneurology/fullarticle/2845466

SOURCE: JAMA Neurology

No comments:

Post a Comment